NY A09516

Prohibits insurers and health care plans from requiring insurer-designated pharmacies to dispense medications directly to patients for transport to physician offices, hospitals, or clinics for administration.

Prohibits requiring home infusion pharmacies for sterile intravenous drugs to patients' homes, though insurers may offer such coverage voluntarily.

Requires insurers establishing agreements with providers for insurer-designated pharmacy distribution to include: 90 days' notice, expedited exception processes, same-day delivery, 24/7 pharmacist access, cold chain logistics, medication pedigree documentation, FDA compliance expertise, national accreditation, ready-to-administer dosage forms, and site-neutral payment covering provider intake, storage, and disposal costs.

Prohibits requiring medications needing sterile compounding by providers or medications with patient-specific dosages based on same-day lab results to be distributed from insurer-designated pharmacies to provider locations.

Applies requirements to all insurers regulated under Insurance Law Articles 32 and 43, and all health care plans under Public Health Law Section 4406-c, effective immediately.